fda glp-1 warning letters september 2025 Targets and Peptide Compounding, Advertising and 'Research Use Only' Labeling 5 GMP Lessons from 2025's

A systematic review executed on animal and human studies alongside case studies (93) demonstrated a dearth of human evidence on the excretion of GLP-1 agonists in breast milk, even though GLP-1 agonists, being large peptides, could be precisely present in human milk, although the exact amount is unclear (89)

6 Additionally, insulin resistance may lead to dopamine degeneration and disrupted glucose metabolism in several brain regions, further exacerbating the progression of PD

these patients may benefit from an emphasis on glycemic control

However, diabetes and obesity themselves are associated with altered gastric digestion, which may affect drug absorption (49)

I also consider other factors, including other medications you take, chronic illnesses (like cancer or diabetes), family history, how much weight you want to lose, and your preferred mode of taking your medication